American International Group Inc. increased its holdings in Danaher Co. (NYSE:DHR) by 2.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 307,493 shares of the conglomerate’s stock after buying an additional 8,212 shares during the period. American International Group Inc.’s holdings in Danaher were worth $28,542,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently bought and sold shares of DHR. GSA Capital Partners LLP boosted its stake in Danaher by 22.3% during the 2nd quarter. GSA Capital Partners LLP now owns 21,912 shares of the conglomerate’s stock valued at $1,849,000 after purchasing an additional 3,991 shares during the period. D.A. Davidson & CO. boosted its stake in Danaher by 17.4% during the 2nd quarter. D.A. Davidson & CO. now owns 10,015 shares of the conglomerate’s stock valued at $845,000 after purchasing an additional 1,483 shares during the period. Vanguard Group Inc. boosted its stake in Danaher by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock valued at $3,501,206,000 after purchasing an additional 520,776 shares during the period. FMR LLC boosted its stake in Danaher by 0.9% during the 2nd quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock valued at $1,656,100,000 after purchasing an additional 183,183 shares during the period. Finally, ETRADE Capital Management LLC boosted its stake in Danaher by 5.1% during the 2nd quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock valued at $1,610,000 after purchasing an additional 917 shares during the period. 75.88% of the stock is owned by hedge funds and other institutional investors.
Shares of Danaher Co. (DHR) opened at $97.54 on Monday. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $104.82. The company has a market cap of $67,946.36, a PE ratio of 27.63, a price-to-earnings-growth ratio of 2.05 and a beta of 1.04. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43.
The firm also recently announced a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were issued a $0.14 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.57%. Danaher’s payout ratio is currently 15.86%.
In related news, CFO Daniel L. Comas sold 62,989 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $101.96, for a total value of $6,422,358.44. Following the sale, the chief financial officer now directly owns 227,805 shares in the company, valued at approximately $23,226,997.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Angela S. Lalor sold 42,988 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the sale, the senior vice president now owns 82,008 shares in the company, valued at $8,388,598.32. The disclosure for this sale can be found here. Insiders sold a total of 237,043 shares of company stock worth $24,194,886 over the last quarter. Insiders own 12.20% of the company’s stock.
A number of research analysts have issued reports on DHR shares. Credit Suisse Group reissued a “hold” rating and set a $99.00 target price on shares of Danaher in a research note on Tuesday, December 19th. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Robert W. Baird reissued a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Royal Bank of Canada reissued a “hold” rating and set a $96.00 target price on shares of Danaher in a research note on Thursday, January 4th. Finally, Evercore ISI began coverage on shares of Danaher in a research note on Wednesday, January 3rd. They set an “outperform” rating for the company. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $100.68.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.com-unik.info/2018/02/19/american-international-group-inc-boosts-stake-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.